Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.

Proceedings of the National Academy of Sciences of the United States of America
Emmanuelle HuillardDavid H Rowitch

Abstract

Although malignant astrocytomas are a leading cause of cancer-related death in children, rational therapeutic strategies are lacking. We previously identified activating mutations of v-raf murine sarcoma viral oncogene homolog B1 (BRAF) (BRAF(T1799A) encoding BRAF(V600E)) in association with homozygous cyclin-dependent kinase inhibitor 2A (CDKN2A, encoding p14ARF and p16Ink4a) deletions in pediatric infiltrative astrocytomas. Here we report that BRAF(V600E) expression in neural progenitors (NPs) is insufficient for tumorigenesis and increases NP cellular differentiation as well as apoptosis. In contrast, astrocytomas are readily generated from NPs with additional Ink4a-Arf deletion. The BRAF(V600E) inhibitor PLX4720 significantly increased survival of mice after intracranial transplant of genetically relevant murine or human astrocytoma cells. Moreover, combination therapy using PLX4720 plus the Cyclin-dependent kinase (CDK) 4/6-specific inhibitor PD0332991 further extended survival relative to either monotherapy. Our findings indicate a rational therapeutic strategy for treating a subset of pediatric astrocytomas with BRAF(V600E) mutation and CDKN2A deficiency.

References

Oct 9, 1998·Genes & Development·J ZhuJ M Bishop
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 2, 2004·Acta Neuropathologica·Christiane B KnobbeGuido Reifenberger
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Sep 12, 2006·Journal of Neurosurgery·Hariyadarshi PannuDianna M Milewicz
Jan 15, 2008·Journal of Neuro-oncology·Muh-Lii LiangCynthia Hawkins
Apr 10, 2008·The Journal of Clinical Investigation·Stefan PfisterPeter Lichter
Mar 14, 2009·Nature Genetics·David DankortMarcus Bosenberg
Apr 7, 2009·Cancer Cell·Nathalie DhomenRichard Marais
Jun 23, 2009·Acta Neuropathologica·Andrey KorshunovChristian Hartmann
Feb 17, 2010·Neuro-oncology·Margaret J DoughertyJaclyn A Biegel
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara S PaughSuzanne J Baker
Jun 24, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dorine A BaxChris Jones
Jan 5, 2011·Journal of Neuro-oncology·José Javier OteroScott Vandenberg
Mar 16, 2011·The Journal of Clinical Investigation·Jan GronychPeter Lichter
Apr 23, 2011·Cancer Research·Roch-Philippe CharlesMartin McMahon
Jun 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric H RaabeCharles G Eberhart
Nov 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Theodore P NicolaidesC David James
Jan 31, 2012·Nature Genetics·Gang WuUNKNOWN St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington

❮ Previous
Next ❯

Citations

Nov 1, 2012·Neuro-oncology·Koichi IchimuraMasao Matsutani
Oct 24, 2012·Neuro-oncology·Nicholas F Marko, Robert J Weil
Sep 20, 2012·Neurosurgery·Phillip V Parry, Johnathan A Engh
Dec 20, 2013·Pathology Oncology Research : POR·Ivan Fernandez-VegaIstvan Bodi
Jul 11, 2014·Cellular and Molecular Life Sciences : CMLS·Iva Simeonova, Emmanuelle Huillard
Sep 19, 2014·Nature Reviews. Cancer·Chris Jones, Suzanne J Baker
Dec 7, 2013·Neuro-oncology·Sabine MuellerDaphne A Haas-Kogan
Jan 8, 2015·Journal of Personalized Medicine·John GlodLorna Rodriguez-Rodriguez
Mar 6, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Muhammad M Abd-El-BarrJohn H Chi
Dec 8, 2015·Glia·Suzanne J BakerDavid H Gutmann
Jan 1, 2015·Nature Reviews. Disease Primers·Michael WellerGuido Reifenberger
Apr 20, 2013·Current Opinion in Pharmacology·Marieke AartsNicholas C Turner
Jun 11, 2016·Neuro-oncology·Chris JonesWilliam A Weiss
Jul 23, 2016·The Journal of Molecular Diagnostics : JMD·Fausto J RodriguezMing-Tseh Lin
Oct 5, 2016·The Journal of Pathology·Jason Ch Chiang, David W Ellison
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominik SturmDavid T W Jones
Nov 14, 2018·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Jehan AlRayahiSuzanne Laughlin
Oct 24, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas KaleyDavid M Hyman
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Sep 23, 2020·Pediatric Blood & Cancer·Paul AridgidesDaphne Haas-Kogan
Jul 28, 2017·Neuromolecular Medicine·Alexia KlonouAthanasios G Papavassiliou
Nov 17, 2016·Journal of Neuro-oncology·Jie ZhangTheodore Nicolaides
Apr 5, 2018·Acta Neuropathologica·Floris P BarthelRoel G W Verhaak
Feb 11, 2015·Advances in Anatomic Pathology·Sriram Venneti, Jason T Huse
Aug 29, 2018·Journal of Neuro-oncology·Jennie W TaylorMichael Prados
Jul 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric RaabeKenneth J Cohen
Nov 4, 2017·Cancer Research·Christopher C MillsValerie B Sampson
Nov 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aleksandra OlowDaphne A Haas-Kogan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Barbara S PaughSuzanne J Baker
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Theodore P NicolaidesC David James
Proceedings of the National Academy of Sciences of the United States of America
W Ruprecht WiedemeyerLynda Chin
© 2021 Meta ULC. All rights reserved